CHOC Children's is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Mark Daniels, MD, the TrialNet team at CHOC Children's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.  

Columbia University is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Robin Goland, MD, the TrialNet team at Columbia University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Julia Warrent-Ulanch, MD, the TrialNet team at Creedmoor Centre Endocrinology is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Creedmoor Centre Endocrinology is regionally overseen by Vanderbilt University Medical Center. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Mark Kipnes, MD, the TrialNet team at Diabetes & Glandular Disease Clinic, PA is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Diabetes & Glandular Disease Clinic, PA is regionally overseen by University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Emory Children’s Center is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Andrew Muir, MD, the TrialNet team at Emory is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by David Hansen, MD, MPH, the TrialNet team at Joslin Center at SUNY Upstate Medical University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Joslin Center at SUNY Upstate Medical University is regionally overseen by Columbia University. If you reach out to TrialNet, you may be contacted by staff from either institution

Joslin Diabetes Center is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Jason Gaglia, MD, MMSc, the TrialNet team at Joslin Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Steven D. Kunkel, MD, the TrialNet team at Kadlec Medical Center Diabetes Learning Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, Kadlec Medical Center Diabetes Learning Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Dr. Mary Pat Gallagher, the TrialNet team at NYU Langone Long Island DBA Pediatric Diabetes Program is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, NYU Langone Long Island DBA Pediatric Diabetes Program is regionally overseen by Columbia University. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Rodica Busui MD, PhD, the TrialNet team at Oregon Health and Science University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Oregon Health and Science University is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution